191 related articles for article (PubMed ID: 33692777)
1. Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers.
Hendaoui I; Lahmar A; Campo L; Mebarki S; Bichet S; Hess D; Degen M; Kchir N; Charrada-Ben Farhat L; Hefaiedh R; Ruiz C; Terracciano LM; Tucker RP; Hendaoui L; Chiquet-Ehrismann R
Front Immunol; 2020; 11():630139. PubMed ID: 33692777
[TBL] [Abstract][Full Text] [Related]
2. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior.
Degen M; Brellier F; Kain R; Ruiz C; Terracciano L; Orend G; Chiquet-Ehrismann R
Cancer Res; 2007 Oct; 67(19):9169-79. PubMed ID: 17909022
[TBL] [Abstract][Full Text] [Related]
5. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
[TBL] [Abstract][Full Text] [Related]
6. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-W: Discovery, Evolution, and Future Prospects.
Degen M; Scherberich A; Tucker RP
Front Immunol; 2020; 11():623305. PubMed ID: 33603752
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
Karamitopoulou E; Tornillo L; Zlobec I; Cioccari L; Carafa V; Borner M; Schaffner T; Brunner T; Diamantis I; Zimmermann A; Terracciano L
Am J Clin Pathol; 2008 Nov; 130(5):780-6. PubMed ID: 18854271
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
12. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro.
Martina E; Degen M; Rüegg C; Merlo A; Lino MM; Chiquet-Ehrismann R; Brellier F
FASEB J; 2010 Mar; 24(3):778-87. PubMed ID: 19884327
[TBL] [Abstract][Full Text] [Related]
14. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
[TBL] [Abstract][Full Text] [Related]
15. The Expression and Possible Functions of Tenascin-W During Development and Disease.
Tucker RP; Degen M
Front Cell Dev Biol; 2019; 7():53. PubMed ID: 31032255
[TBL] [Abstract][Full Text] [Related]
16. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
Terada T; Nakanuma Y
Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
[TBL] [Abstract][Full Text] [Related]
17. Expansion of the nonadherent myeloid cell population by monoclonal antibodies against tenascin-C in murine long-term bone marrow cultures.
Talts JF; Falk M; Ekblom M
Exp Hematol; 1998 Jul; 26(7):552-61. PubMed ID: 9657129
[TBL] [Abstract][Full Text] [Related]
18. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
20. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]